Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 89,856 | 3,497 | N/A |
| Receivables | 2,118 | 33 | N/A |
| TOTAL | $94,221 | $3,978 | $N/A |
| Non-Current Assets | |||
| PPE Net | 2,713 | 184 | N/A |
| Other Non-Current Assets | 360 | 121 | 0 |
| TOTAL | $3,073 | $305 | $N/A |
| Total Assets | $97,294 | $4,283 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 3,891 | 698 | 0 |
| Accrued Expenses | 6,864 | 1,715 | N/A |
| Other current liabilities | N/A | 1,402 | N/A |
| TOTAL | $10,755 | $3,815 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 134 | 16,992 | 0 |
| TOTAL | $134 | $16,992 | $N/A |
| Total Liabilities | $10,889 | $20,807 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1,145 | N/A | N/A |
| Retained earnings | -59,744 | -19,657 | N/A |
| Other shareholders' equity | 138,196 | -271 | 0 |
| TOTAL | $86,405 | $-16,524 | $N/A |
| Total Liabilities And Equity | $97,294 | $4,283 | $0 |